Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Keyphrases
Abdominal
14%
Albendazole
14%
Animal Health
14%
Antibiotics
17%
Antimicrobial Resistance
35%
Antimicrobial Susceptibility Pattern
14%
Bloodstream Infection
18%
Carbapenem Resistance
9%
Carbapenems
11%
Clinical Tropical Medicine
14%
COVID-19
29%
COVID-19 Mortality
14%
Cryptococcosis
14%
Cusco
50%
Cyst
14%
ESBL-producing
14%
Escherichia Coli
14%
Extended-spectrum-lactamase
14%
Fascioliasis
14%
Flavus
14%
Gram-negative Bacteria
17%
High Altitude
19%
Hospitalized Patients
44%
Human T-cell Leukemia Virus Type 1 (HTLV-1)
14%
Hydatidosis
14%
Klebsiella Pneumoniae (K. pneumoniae)
12%
Lambda
14%
Medical Treatment
14%
Methicillin-resistant Staphylococcus Aureus
14%
Multicenter Cohort Study
14%
Natural Selection
14%
Non-HIV Cryptococcal Meningitis
14%
Peru
100%
Peruvian
49%
Point Prevalence Survey
14%
Potential Threats
14%
Public Health
14%
Rabies
14%
Resistance Dynamics
14%
Resistance Pattern
10%
Risk Factors
17%
Seroprevalence
14%
Severe Acute Respiratory Syndrome Coronavirus 2 Variants
14%
Staphylococcus Aureus Bloodstream Infection
14%
Subcapsular Liver Hematoma
14%
Surgical Removal
14%
Uropathogenic E. Coli
14%
Uropathogenic Escherichia Coli
14%
Variants of Concern
14%
Young Males
14%
Medicine and Dentistry
Albendazole
14%
Antibiotic Resistance
28%
Assisted Ventilation
7%
Bacterium Isolate
5%
Bloodstream Infection
14%
Cohort Analysis
14%
Combination Therapy
14%
COVID-19
14%
Cryptococcosis
14%
Echinococcosis
14%
Escherichia coli
5%
Extended Spectrum Beta Lactamase
14%
Fascioliasis
14%
Gram-Negative Bacteria
14%
Human T-Lymphotropic Virus 1
14%
Infection
17%
Intensive Care Unit
7%
Liver Hematoma
14%
Natural Selection
14%
Penicillinase
14%
Prevalence
14%
Pseudomonas aeruginosa
5%
Severe Acute Respiratory Syndrome Coronavirus 2
14%
Surgical Drainage
7%
Tropical Disease
14%
Urinary Tract Infection
5%
Uropathogenic Escherichia Coli
14%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotic Resistance
42%
Antibiotics
17%
Antiinfective Agent
5%
Bloodstream Infection
28%
Carbapenem Derivative
18%
Cephalosporin Derivative
7%
Combination Therapy
6%
Cryptococcal Meningitis
14%
Escherichia coli
12%
Extended Spectrum Beta Lactamase
14%
Fascioliasis
14%
Gram Negative Bacterium
17%
HIV
14%
Klebsiella pneumoniae
5%
Liver Hematoma
14%
Methicillin-Resistant Staphylococcus Aureus
14%
Penicillinase
14%
Prevalence
28%
Pseudomonas aeruginosa
5%
Staphylococcus Aureus
7%
Third Generation Cephalosporin
5%
Urinary Tract Infection
5%
Uropathogenic Escherichia Coli
14%